Reported Consolidated quarterly numbers for Fortis Healthcare are:Net Sales at Rs 605.95 crore in June 2020 down 46.77% from Rs. 1,138.31 crore in June 2019.
Quarterly Net Loss at Rs. 178.92 crore in June 2020 down 363.85% from Rs. 67.81 crore in June 2019.
EBITDA stands negative at Rs. 98.84 crore in June 2020 down 161.07% from Rs. 161.84 crore in June 2019.
Fortis Health shares closed at 135.40 on August 14, 2020 (NSE) and has given -13.26% returns over the last 6 months and 6.03% over the last 12 months.
| Fortis Healthcare | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Jun'20 | Mar'20 | Jun'19 | | Net Sales/Income from operations | 605.95 | 1,112.92 | 1,138.31 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 605.95 | 1,112.92 | 1,138.31 | | EXPENDITURE | | Consumption of Raw Materials | 147.88 | 233.68 | 242.11 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -- | -- | -- | | Power & Fuel | -- | -- | -- | | Employees Cost | 206.22 | 218.70 | 235.91 | | Depreciation | 71.65 | 80.08 | 70.95 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 355.14 | 534.76 | 518.01 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -174.94 | 45.70 | 71.33 | | Other Income | 4.45 | 18.41 | 19.56 | | P/L Before Int., Excpt. Items & Tax | -170.49 | 64.11 | 90.89 | | Interest | 41.08 | 56.95 | 50.92 | | P/L Before Exceptional Items & Tax | -211.57 | 7.16 | 39.97 | | Exceptional Items | 0.45 | -- | 9.50 | | P/L Before Tax | -211.12 | 7.16 | 49.47 | | Tax | -20.38 | 50.42 | -25.72 | | P/L After Tax from Ordinary Activities | -190.74 | -43.26 | 75.19 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -190.74 | -43.26 | 75.19 | | Minority Interest | 8.96 | -3.27 | -10.20 | | Share Of P/L Of Associates | 2.86 | 2.02 | 2.82 | | Net P/L After M.I & Associates | -178.92 | -44.51 | 67.81 | | Equity Share Capital | 754.96 | 754.96 | 754.96 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -2.37 | -0.59 | 0.90 | | Diluted EPS | -2.37 | -0.59 | 0.90 | | EPS After Extra Ordinary | | Basic EPS | -2.37 | -0.59 | 0.90 | | Diluted EPS | -2.37 | -0.59 | 0.90 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
First Published on Aug 17, 2020 10:55 am
